RecruitingNCT07790614

Photon-counting CT Scan vs Standard HRCT Scan in the Identification of Idiopathic Pulmonary Fibrosis

Sponsor

Istituto Clinico Humanitas

Enrollment

156 participants

Start Date

Mar 25, 2025

Study Type

OBSERVATIONAL

Conditions

Idiopathic Pulmonary Fibrosis ILD CT Interstitial Lung Disease (ILD)Idiopathic Pulmonary Fibrosis (IPF)IPF Interstitial Lung Diseases CT Photon Counting CT Scan Interstitial Lung Disease Due to Systemic Disease (Telomere Biology Disorder)

Summary

The CT-IPF ANTHEM study is designed to prospectively compare PCDCT to HRCT scan in the identification of specific ILD diagnosis discussed during the multidisciplinary discussion to increase diagnostic confidence and reduce unclassifiable ILD cases.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Photon counting CT for people with ct, ct photon counting, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIAGNOSTIC_TESTPhoton counting CT

Non-contrast enhanced CT will be acquired in spectral ultra-high-resolution mode on a clinical dual-source photon-counting detector CT (PCDCT) (NAEOTOM Alpha, Siemens Healthineers AG, Forchheim, Germany). All scans will be acquired with automated exposure control.

Locations(1)

Humanitas Research Hospital

Rozzano, Italy, Italy

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07790614

Related Trials

Study to Evaluate the Efficacy, Safety, and Tolerability of PIPE 791 in Subjects With Idiopathic Pulmonary Fibrosis

NCT0728445953 locations

A Study to Test Whether Nerandomilast Helps People With Lungfibrosis Related to Rheumatic Diseases

NCT06806592156 locations

A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis

NCT0720192256 locations

A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis

NCT0696884530 locations

Trial to Evaluate the Efficacy and Safety of LYT-100 (Deupirfenidone) Compared to Pirfenidone in Adults With Idiopathic Pulmonary Fibrosis (IPF)

NCT072846029 locations